Rhynchophylline Loaded-mPEG-PLGA Nanoparticles Coated with Tween-80 for Preliminary Study in Alzheimer’s Disease

Código QR

Rhynchophylline Loaded-mPEG-PLGA Nanoparticles Coated with Tween-80 for Preliminary Study in Alzheimer’s Disease

Ruiling Xu, 1 Junying Wang, 1 Juanjuan Xu, 1 Xiangrong Song, 2 Hai Huang, 2 Yue Feng, 3 Chunmei Fu 1 1Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province, Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Xu R, Wang J, Xu J, Song X, Huang H, Feng Y, Fu C
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2020
Materias:	alzheimer’s disease rhynchophylline nanoparticles blood brain barrier neuroprotective effect Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/8643d94c34834c3b99968e26c4224e69
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

PPARγ agonist-loaded PLGA-PEG nanocarriers as a potential treatment for Alzheimer’s disease: in vitro and in vivo studies
por: Silva-Abreu M, et al.
Publicado: (2018)

Solid lipid nanoparticle delivery of rhynchophylline enhanced the efficiency of allergic asthma treatment via the upregulation of suppressor of cytokine signaling 1 by repressing the p38 signaling pathway
por: Chuanfeng Lv, et al.
Publicado: (2021)

Physiologically based pharmacokinetic modeling of PLGA nanoparticles with varied mPEG content
por: Avgoustakis K, et al.
Publicado: (2012)

Therapeutic Potential of Mitophagy-Inducing Microflora Metabolite, Urolithin A for Alzheimer’s Disease
por: Dona Pamoda W. Jayatunga, et al.
Publicado: (2021)

Transferrin-Modified Osthole PEGylated Liposomes Travel the Blood-Brain Barrier and Mitigate Alzheimer’s Disease-Related Pathology in APP/PS-1 Mice
por: Kong L, et al.
Publicado: (2020)

Wheat germ agglutinin-conjugated liposomes incorporated with cardiolipin to improve neuronal survival in Alzheimer’s disease treatment
por: Kuo YC, et al.
Publicado: (2017)

Mithramycin-loaded mPEG-PLGA nanoparticles exert potent antitumor efficacy against pancreatic carcinoma
por: Liu XJ, et al.
Publicado: (2017)

Codelivery of SH-aspirin and curcumin by mPEG-PLGA nanoparticles enhanced antitumor activity by inducing mitochondrial apoptosis
por: Zhou L, et al.
Publicado: (2015)

Degradability, bioactivity, and osteogenesis of biocomposite scaffolds of lithium-containing mesoporous bioglass and mPEG-PLGA-b-PLL copolymer
por: Cai Y, et al.
Publicado: (2015)

Late onset Alzheimer’s disease in older people
por: Ahmet Turan Isik
Publicado: (2010)

Bufalin-loaded mPEG-PLGA-PLL-cRGD nanoparticles: preparation, cellular uptake, tissue distribution, and anticancer activity
por: Duan YR, et al.
Publicado: (2012)

Intranasal delivery of Huperzine A to the brain using lactoferrin-conjugated N-trimethylated chitosan surface-modified PLGA nanoparticles for treatment of Alzheimer’s disease
por: Meng QQ, et al.
Publicado: (2018)

Alzheimer's research & therapy
Publicado: (2009)

Targeting neuroinflammation in Alzheimer’s disease
por: Bronzuoli MR, et al.
Publicado: (2016)

Tween<sup>®</sup> Preserves Enzyme Activity and Stability in PLGA Nanoparticles
por: Jason Thomas Duskey, et al.
Publicado: (2021)

Tempeh & Soybean Seed Coat: The Alternative Sources of Trans-Resveratrol as Neuroprotective Agents
por: Irnidayanti,Yulia, et al.
Publicado: (2019)

The occurrence of cerebrovascular atherosclerosis in Alzheimer’s disease patients
por: Yuan J, et al.
Publicado: (2013)

Synthesis, characterization, and evaluation of mPEG–SN38 and mPEG–PLA–SN38 micelles for cancer therapy
por: Xie J, et al.
Publicado: (2016)

Journal of Alzheimer's disease
Publicado: (1998)

Galantamine-ER for the treatment of mild-to-moderate Alzheimer’s disease
por: Ben Seltzer
Publicado: (2009)

Management of psychosis in patients with Alzheimer’s disease: focus on aripiprazole
por: Subramanian Madhusoodanan, et al.
Publicado: (2008)

Multi-Target Effects of Novel Synthetic Coumarin Derivatives Protecting Aβ-GFP SH-SY5Y Cells against Aβ Toxicity
por: Ching-Chia Huang, et al.
Publicado: (2021)

TLR-Mediated Signal Transduction and Neurodegenerative Disorders
por: Shashank Vishwanath Adhikarla, et al.
Publicado: (2021)

Enhancement and analysis of Anthracene degradation by Tween 80 in LMS-HOBt
por: Zuoyi Yang, et al.
Publicado: (2021)

Development of surface-engineered PLGA nanoparticulate-delivery system of Tet-1-conjugated nattokinase enzyme for inhibition of Aβ40 plaques in Alzheimer’s disease
por: Bhatt PC, et al.
Publicado: (2017)

Bilingualism as a strategy to delay the onset of Alzheimer’s disease
por: Klimova B, et al.
Publicado: (2017)

All roads lead to Rome — a review of the potential mechanisms by which exerkines exhibit neuroprotective effects in Alzheimer’s disease
por: Yi-Yao Liang, et al.
Publicado: (2022)

N-oleoylethanolamine − phosphatidylcholine complex loaded, DSPE-PEG integrated liposomes for efficient stroke
por: Xiangrui Yang, et al.
Publicado: (2021)

Development of TIMP1 magnetic nanoformulation for regulation of synaptic plasticity in HIV-1 infection
por: Atluri VSR, et al.
Publicado: (2016)

The role of rasagiline in the treatment of Parkinson’s disease
por: Julie Leegwater-Kim, et al.
Publicado: (2010)

Effect of genetic polymorphisms on Alzheimer’s disease treatment outcomes: an update
por: Sumirtanurdin R, et al.
Publicado: (2019)

Importance of hypoglycemia on the risk of Alzheimer’s disease in elderly subjects with diabetes mellitus
por: Muratli S, et al.
Publicado: (2015)

Spaced Retrieval and Episodic Memory Training in Alzheimer’s Disease
por: Small JA, et al.
Publicado: (2020)

Associations between apolipoprotein E gene polymorphisms and Alzheimer’s disease risk in a large Chinese Han population
por: Wu P, et al.
Publicado: (2015)

Olfactory dysfunction in Alzheimer’s disease
por: Zou YM, et al.
Publicado: (2016)

Altered diastolic function and aortic stiffness in Alzheimer’s disease
por: Çalık AN, et al.
Publicado: (2014)

Importance and management of micronutrient deficiencies in patients with Alzheimer’s disease
por: Cardoso BR, et al.
Publicado: (2013)

Positron Emission Tomography in Animal Models of Alzheimer’s Disease Amyloidosis: Translational Implications
por: Ruiqing Ni
Publicado: (2021)

Extensive frontal focused ultrasound mediated blood–brain barrier opening for the treatment of Alzheimer’s disease: a proof-of-concept study
por: So Hee Park, et al.
Publicado: (2021)

Variabilidad y variantesde la enfermedad de Alzheimer
por: Donoso S,Archibaldo, et al.
Publicado: (2005)